Applied BioPhotonics Ltd

Applied BioPhotonics Ltd (ABP) is a manufacturer of photobiomodulation therapy (PBT) devices and systems that use light energy to non-invasively stimulate cellular healing and recovery. The company's flagship Mark II system employs LED-based red, infrared, blue, violet, and green wavelengths delivered via flexible, hypoallergenic 3D LightPads to treat tissue-specific conditions. Products are marketed globally under regional brands: LightMD (USA/Europe), AraLight (India/Middle East/Africa), LightDr (Asia/Japan), PetLight (veterinary), and EquineLight (equine). The system features the proprietary LightOS user interface with dozens of tissue-specific treatment protocols, interchangeable pad configurations for different body parts, and precise pulse frequency controls. Clinical applications span pain management, inflammation reduction, musculoskeletal injury recovery, post-operative healing, circulation improvement, fatigue reduction, concussion recovery, and dermatological conditions. ABP serves physicians, hospitals, physical therapists, chiropractors, dermatologists, surgical specialists, dentists, wellness clinics, athletic trainers, and veterinarians. The company holds FDA audit approval, ISO 13485 certification, Taiwan FDA clearance, IEC eye-safety rating, FCC clearance, GMP manufacturing certification, CE marking, and RoHS compliance. Products are non-invasive, non-toxic, non-addictive, and classified as non-pharmaceutical devices. Manufacturing emphasizes medical-grade quality polymers, hypoallergenic materials, and rigorous safety testing.